Quality of Life Before and After Liver Transplantation for Cholestatic Liver Disease
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Liver transplantation (LT) is an established therapy for patients with end–stage primary biliary cirrhosis (PBC) or primary sclerosing cholangitis (PSC). In this report, we describe the health status and quality of life (QOL) in patients with these cholestatic liver diseases before and after LT. A QOL questionnaire was completed by 157 adult patients with PBC or PSC before and 1 year after liver transplantation at the Mayo Clinic or Baylor University Medical Center. This questionnaire measured four aspects of QOL, including symptoms; physical, social, and emotional functioning; health perceptions; and overall QOL. Changes in these QOL parameters before and after LT were described, and regression analysis was used to assess the relationships between clinical and QOL factors. There were no differences in QOL parameters between patients with PBC and PSC. QOL following transplantation was substantially better than before transplantation. This was observed in all four aspects of QOL. The degree of improvement as measured by effect size (difference in mean scores divided by the pretransplantation standard deviation) was 0.53 for symptoms (P<.01), 1.16 for function (P < .01), 2.37 for health satisfaction (P < .01), and 1.16 for overall QOL (P< .01). Patients' overall QOL before transplantation was significantly related to subjective and objective health status indicators and clinical factors such as ascites and renal dysfunction. QOL at 1–year follow–up, however, could not be adequately predicted by the pretransplantation subjective health status and clinical factors. Patients with end–stage cholestatic disease undergoing LT experience substantial improvement in all aspects of QOL addressed in this study. The patients' QOL 1 year after LT could not be predicted by pretransplantation variables used in this study
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Liver transplantation for cholestatic pruritus is highly effective in terms of rapid reduction in pruritus severity (frequently within the first 24 h of transplantation) [212].”
From EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. (2017) · cites this paper as [212]
In the citing paper
“Liver transplantation for cholestatic pruritus is highly effective in terms of rapid reduction in pruritus severity (frequently within the first 24 hours of transplantation).204”
From The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines (2018) · cites this paper as [204]
Citations
Cites
Diener, E. (1984) · Psychological Bulletin · doi:10.1037/0033-2909.95.3.542 · Cited by 11,023
Diener, E. (2009) · Social Indicators Research Series · doi:10.1007/978-90-481-2350-6_2 · Cited by 10,950
Взаимосвязь статуса занятости и пола с уровнем психологического благополучия
М.Р., Н., & С.И., Б. (2026) · Cifra LLC Journals · doi:10.60797/irj.2026.170.43 · Cited by 7,950
Multiple comparisons among means
Dunn, O. J. (1961) · Journal of the American Statistical Association · doi:10.1080/01621459.1961.10482090 · Cited by 5,006
The Structure of Psychological Well-Being.
Mechanic, D., & Bradburn, N. M. (1970) · American Sociological Review · doi:10.2307/2093340 · Cited by 4,923
The MOS Short-form General Health Survey: Reliability and Validity in a Patient Population
Stewart, A. L., Hays, R. D., & Ware, J. E. (1988) · Medical Care · doi:10.1097/00005650-198807000-00007 · Cited by 3,339
Users' guides to the medical literature
Guyatt, G. H. (1993) · JAMA · doi:10.1001/jama.270.17.2096 · Cited by 2,970
The clinical evaluation of chemotherapeutic agents in cancer
Karnofsky, D. A. (1949) · Medical Entomology and Zoology · Cited by 2,933
Effect Sizes for Interpreting Changes in Health Status
Kazis, L. E., Anderson, J. J., & Meenan, R. F. (1989) · Medical Care · doi:10.1097/00005650-198903001-00015 · Cited by 2,401
Motamedi, K. K., Campbell, A., Converse, P. E., & Rodgers, W. L. (1977) · The Academy of Management Review · doi:10.2307/257525 · Cited by 1,954
Research works printed but not linked: 4
- Price, 1995, J Royal Soc Med, 88, 130
- Hunt, 1985, J R Coll Gen Pract, 35, 185
- Statistical Power Analysis for the Behavorial Sciences. 2nd ed. Hillsdale, New Jersey: Lawrence Erlbaum Associates. 1988;8-17.
- Adams, 1995, Hepatology, 21, 140
Cited by
EASL Clinical Practice Guidelines: management of cholestatic liver diseases
European Association for the Study of the Liver (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.04.009 · Cited by 1,729
“Transplantation is effective for the control of cholestatic itch but raises issues of organ allocation priority and patient risk in patients who would not otherwise require transplantation [228].”
BackgroundHirschfield, G. M., Beuers, U., Corpechot, C., Invernizzi, P., Jones, D., Marzioni, M., & Schramm, C. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.03.022 · Cited by 1,480
“Liver transplantation for cholestatic pruritus is highly effective in terms of rapid reduction in pruritus severity (frequently within the first 24 h of transplantation) [212].”
Primary sclerosing cholangitis – a comprehensive review
Karlsen, T. H., Folseraas, T., Thorburn, D., & Vesterhus, M. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.07.022 · Cited by 868
Primary sclerosing cholangitis
Hirschfield, G. M., Karlsen, T. H., Lindor, K. D., & Adams, D. H. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60096-3 · Cited by 592
Factors associated with poor health-related quality of life of patients with cirrhosis
Marchesini, G., Bianchi, G., Amodio, P., Salerno, F., Merli, M., Panella, C., Loguercio, C., Apolone, G., Niero, M., & Abbiati, R. (2001) · Gastroenterology · doi:10.1053/gast.2001.21193 · Cited by 501
AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma
Bowlus, C. L., Arrivé, L., Bergquist, A., Deneau, M., Forman, L., Ilyas, S. I., Lunsford, K. E., Martinez, M., Sapisochin, G., Shroff, R., et al. (2023) · Hepatology · doi:10.1002/hep.32771 · Cited by 428
Hirschfield, G. M., Dyson, J. K., Alexander, G. J. M., Chapman, M. H., Collier, J., Hübscher, S., Patanwala, I., Pereira, S. P., Thain, C., Thorburn, D., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-315259 · Cited by 362
Branched-chain amino acids as pharmacological nutrients in chronic liver disease
Kawaguchi, T., Izumi, N., Charlton, M. R., & Sata, M. (2011) · Hepatology · doi:10.1002/hep.24412 · Cited by 331
“Generally, the overall health status and QOL of patients with liver cirrhosis is poor.(65,66) Patients with cirrhosis frequently complain of fatigue and sleep disturbances.”
BackgroundJacoby, A., Rannard, A., Buck, D., Bhala, N., Newton, J. L., James, O. F. W., & Jones, D. E. J. (2005) · Gut · doi:10.1136/gut.2005.065862 · Cited by 267
“diseases [2,4, 7-12 ]. The relevance and appropriateness of the application of these generic”
BackgroundAutoimmune liver disease, autoimmunity and liver transplantation
Carbone, M., & Neuberger, J. M. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.09.020 · Cited by 250
“Cross-sectional studies have shown no evidence of improved fatigue after LT [48,49].”
BackgroundQuality of life measurement in gastrointestinal and liver disorders
BORGAONKAR, M. R., & IRVINE, E. J. (2000) · Gut · doi:10.1136/gut.47.3.444 · Cited by 220
Gralnek, I. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)02168-7 · Cited by 199
The true impact of fatigue in primary biliary cirrhosis: A population study
Goldblatt, J., Taylor, P. J. S., Lipman, T., Prince, M. I., Baragiotta, A., Bassendine, M. F., James, O. F. W., & Jones, D. E. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.32993 · Cited by 202
Psychological status and depression in patients with liver cirrhosis
Bianchi, G., Marchesini, G., Nicolino, F., Graziani, R., Sgarbi, D., Loguercio, C., Abbiati, R., & Zoli, M. (2005) · Digestive and Liver Disease · doi:10.1016/j.dld.2005.01.020 · Cited by 187
Quality of life after liver transplantation. A systematic review
Tome, S., Wells, J. T., Said, A., & Lucey, M. R. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2007.12.013 · Cited by 170
“25 Gevarghese/1998 [33] 100 46 72 Karnofsky P 26 Gross/1999 [23] 157 50 12 Karnofsky, NIDDK LT Functioning (MOS, NHP 27 Singh/1998 [13] 59 48 12 BDI, WCS, Karnofsky, 28 Moore/2000 [26] 27 44 9 AUSQUAL REY Bento Controlled O Association 29 De Bona/2000 [15] 141 46 60 LEIPAD, B 30 Caccamo/2001 [34] 33 46 12 SCL-90R m WC…”
MethodResultCognitive impairment in primary biliary cirrhosis: Symptom impact and potential etiology†
Newton, J. L., Hollingsworth, K. G., Taylor, R., El‐Sharkawy, A. M., Khan, Z. U., Pearce, R., Sutcliffe, K., Okonkwo, O., Davidson, A., Burt, J., et al. (2008) · Hepatology · doi:10.1002/hep.22371 · Cited by 156
Kitajima, Y., Takahashi, H., Akiyama, T., Murayama, K., Iwane, S., Kuwashiro, T., Tanaka, K., Kawazoe, S., Ono, N., Eguchi, T., et al. (2017) · Journal of Gastroenterology · doi:10.1007/s00535-017-1370-x · Cited by 157
Ratcliffe, J., Longworth, L., Young, T., Bryan, S., Burroughs, A. K., & Buxton, M. (2002) · Liver Transplantation · doi:10.1053/jlts.2002.31345 · Cited by 149
“0) 5 (4) Cirrhosis: unknown causes 16 (3.”
Bona, M. D., Ponton, P., Ermani, M., Iemmolo, R. M., Feltrin, A., Boccagni, P., Gerunda, G. E., Naccarato, R., Rupolo, G., & Burra, P. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80012-4 · Cited by 145
Quality of life in patients with primary biliary cirrhosis
Poupon, R. E., Chrétien, Y., Chazouillères, O., Poupon, R., & Chwalow, J. (2004) · Hepatology · doi:10.1002/hep.20276 · Cited by 144
Gross, C. R., Kreitzer, M. J., Thomas, W., Reilly-Spong, M., Cramer–Bornemann, M., Nyman, J. A., Frazier, P. A., & Ibrahim, H. N. (2010) · PubMed · Cited by 182
Self-citationPrince, M. I., James, O., Holland, N. P., & Jones, D. E. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80385-2 · Cited by 141
O’Carroll, R. E., Couston, M., Cossar, J., Masterton, G., & Hayes, P. C. (2003) · Liver Transplantation · doi:10.1053/jlts.2003.50138 · Cited by 144
“In this report, we aim to address eight main research questions: (1) What is the psychological status of patients referred for assessment for liver transplantation in Scotland? (2) Is psychological status at assessment related to severity of liver disease? (3) Can patients who are considered not suitable for transplan…”
BackgroundHealth-related quality of life in pediatric liver transplant recipients: A single-center study
Bucuvalas, J. C., Britto, M., Krug, S., Ryckman, F. C., Atherton, H., Alonso, M. P., Balistreri, W. F., & Kotagal, U. (2003) · Liver Transplantation · doi:10.1053/jlts.2003.50012 · Cited by 134
“The goals of the present study were (1) to measure healthrelated quality of life (HRQOL) in pediatric liver transplantation (LT), (2) to identify demographic and clinical factors that correlate with HRQOL, and (3) to compare two instruments that have been used to measure HRQOL in children and adolescents.”
BackgroundKirchner, G. I., Rifai, K., Cantz, T., Nashan, B., Terkamp, C., Becker, T., Strassburg, C. P., Barg‐Hock, H., Wagner, S., Lück, R., et al. (2006) · Liver Transplantation · doi:10.1002/lt.20780 · Cited by 117
“005) in comparison to liver transplantation alone (35 17 [13-76] days) (Tables 1 and 2).”
BackgroundResultCarbone, M., Bufton, S., Monaco, A., Griffiths, L., Jones, D. E., & Neuberger, J. M. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.04.017 · Cited by 115
“[12] in 1999; however, in that study, fatigue was assessed using generic questionnaires not validated in PBC in 157 patients (either with primary biliary cirrhosis or primary sclerosing cholangitis).”
Sanchez, E. Q., Levy, M. F., Goldstein, R. M., Fasola, C. G., Tillery, G. W., Netto, G. J., Watkins, D. L., Weinstein, J. S., Murray, N. G., Byers, D., et al. (2003) · Transplantation · doi:10.1097/01.tp.0000090867.83666.f7 · Cited by 113
“The timing of transplantation must be optimized and performed before the point of rapid clinical deterioration, not only to save the patient’s life but also to improve the quality of life posttransplant (3).”
BackgroundSelf-citationA review of quality of life instruments used in liver transplantation
Jay, C. L., Butt, Z., Ladner, D. P., Skaro, A. I., & Abecassis, M. M. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.07.010 · Cited by 104
Liver transplantation and autoimmune liver diseases
Liberal, R., Zen, Y., Mieli‐Vergani, G., & Vergani, D. (2013) · Liver Transplantation · doi:10.1002/lt.23704 · Cited by 107
“AMAs are found in 90% to 95% of PBC patients and in less than 1% of healthy subjects.20 The natural course of PBC differs from patient to patient: although minimal or no progression is observed in some patients over several decades, others progress to liver failure within 10 years of their diagnosis.21 The natural his…”
BackgroundInfluentialFatigue and physical function after orthotopic liver transplantation
Aadahl, M., Hansen, B. A., Kirkegaard, P., & Groenvold, M. (2002) · Liver Transplantation · doi:10.1053/jlts.2002.31743 · Cited by 100
“SF-36 scores of the following three groups of diagnoses were compared: (1) alcoholic or cryptogenic cirrhosis; (2) primary biliary cirrhosis, primary sclerosing cholangitis, or hepatitis; and (3) other diagnoses, which represent patients with acute liver failure, cancer, or other not primarily cirrhotic liver diseases.”
BackgroundApproach to a Patient with Elevated Serum Alkaline Phosphatase
Siddique, A., & Kowdley, K. V. (2012) · Clinics in Liver Disease · doi:10.1016/j.cld.2012.03.012 · Cited by 98
“UDCA has not been shown to be useful, and fatigue may persist even after liver transplant, although its intensity may be reduced.(198,199) Central nervous system stimulants such as modafinil and low-dose amitriptyline may be beneficial in some patients.”
BackgroundKaram, V. H., Castaing, D., Danet, C., Delvart, V., Gasquet, I., Adam, R. A., Azoulay, D., Samuel, D., & Bismuth, H. (2003) · Liver Transplantation · doi:10.1053/jlts.2003.50148 · Cited by 94
“54 (29) Time point in waiting list at which QOL was assessed (days), median (range) 27 (2-210) 705 Changes in Quality of Life After Liver Transplantation”
BackgroundPrimary sclerosing cholangitis
Silveira, M. G., & Lindor, K. D. (2008) · Canadian Journal of Gastroenterology · doi:10.1155/2008/824168 · Cited by 93
Longitudinal Impact of Mindfulness Meditation on Illness Burden in Solid-Organ Transplant Recipients
Kreitzer, M. J., Gross, C. R., Ye, X., Russas, V., & Treesak, C. (2005) · Progress in Transplantation · doi:10.1177/152692480501500210 · Cited by 92
“Although survival rates have increased significantly, solid-organ transplant recipients still commonly experience a myriad of posttransplant symptoms related to ongoing underlying disease processes, as well as medical complications such as hypertension, hypercholesterolemia, diabetes, and osteoporosis.(3-5) Symptoms o…”
BackgroundSelf-citationLiver transplantation in PBC and PSC: Indications and disease recurrence
Carbone, M., & Neuberger, J. (2011) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2011.02.007 · Cited by 92
“hronic fatigue itself is not an indication for transplantation s available evidence suggests that it may not improved by his procedure [34].”
BackgroundKarlsen, T. H., Vesterhus, M., & Boberg, K. M. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12581 · Cited by 86
Fatigue is a major problem after liver transplantation
van den Berg-Emons, R. J. G., van Ginneken, B. T. J., Wijffels, M. P. J. M., Tilanus, H. W., Metselaar, H. J., Stam, H. J., & Kazemier, G. (2006) · Liver Transplantation · doi:10.1002/lt.20684 · Cited by 97
“For example, Gross et al.(6) and Belle et al.”
BackgroundMethodResultInfluentialS2k Leitlinie Autoimmune Lebererkrankungen: AWMF-Reg. Nr. 021-27
Authors, Collaborators:, durch:, E. B., Deutsche Gesellschaft für Gastroenterologie, V. U. S. (. (., (DGIM), D. G. F. I. M., (DCCV), D. M. C. U. V., e.V., D. L., (DEGUM), D. G. F. U. I. D. M., (DGE-BV), D. G. F. E. U. B. V., (DGKJ), D. G. F. K. U. J., et al. (2017) · Zeitschrift für Gastroenterologie · doi:10.1055/s-0043-120199 · Cited by 90
“Dementsprechend ist gerade bei Patienten kurz vor der Transplantation die Lebensqualität erheblich reduziert, wobei mehrere Studien zeigen konnten, dass es nach erfolgreicher Lebertransplantation zu einer erheblichen Verbesserung der Lebensqualität kommt [441, 442].”
BackgroundRecent Advances in Liver Transplantation
Wiesner, R. H., Rakela, J. L., Ishitani, M. B., Mulligan, D. C., Spivey, J. R., Steers, J. L., & Krom, R. A. F. (2003) · Mayo Clinic Proceedings · doi:10.4065/78.2.197 · Cited by 88
Self-citationNeuberger, J. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80426-2 · Cited by 74
Gossard, A. A., & Talwalkar, J. A. (2013) · Medical Clinics of North America · doi:10.1016/j.mcna.2013.09.002 · Cited by 78
FATIGUE, LEVEL OF EVERYDAY PHYSICAL ACTIVITY AND QUALITY OF LIFE AFTER LIVER TRANSPLANTATION
van den Berg-Emons, R., Kazemier, G., van Ginneken, B., Nieuwenhuijsen, C., Tilanus, H., & Stam, H. (2006) · Journal of Rehabilitation Medicine · doi:10.1080/16501970500338771 · Cited by 67
“(5) showed that, although the intensity of fatigue was reduced compared with prior to liver transplantation, fatigue remained the most distressing symptom one year after the transplantation.”
BackgroundPells, G., Mells, G. F., Carbone, M., Newton, J. L., Bathgate, A. J., Burroughs, A. K., Heneghan, M. A., Neuberger, J. M., Day, D. B., Ducker, S. J., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.02.019 · Cited by 65
“05 PBC-40 cognitive 13 [6-30] 13 [6-30] n.”
BackgroundInfluentialFactors That Reduce Health-Related Quality of Life in Patients With Primary Sclerosing Cholangitis
Valle, M., Rahman, M., Lindkvist, B., Bjornsson, E. S., Chapman, R. W., & Kalaitzakis, E. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.01.025 · Cited by 69
Long-term survival after liver transplantation for alcoholic liver disease
Iruzubieta, P., Crespo, J., & Fábrega, E. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i48.9198 · Cited by 67
Masala, D., Mannocci, A., Unim, B., Cimmuto, A. D., Turchetta, F., Gatto, G., Santoro, R., Ettorre, G. M., Boccia, A., & Torre, G. L. (2012) · Transplantation Proceedings · doi:10.1016/j.transproceed.2012.01.123 · Cited by 64
Physical fitness, fatigue, and quality of life after liver transplantation
van Ginneken, B. T. J., van den Berg-Emons, R. J. G., Geert Kazemier, M., Metselaar, H. J., Tilanus, H. W., & Stam, H. J. (2007) · European Journal of Applied Physiology · doi:10.1007/s00421-007-0435-6 · Cited by 62
“Gross et al. (1999), and Belle et al. (1997) reported that, although the intensity of fatigue was reduced after LTx, fatigue remained the most distressing symptom 1 year after surgery.”
BackgroundInfluentialFactors Related to Fatigue in Patients With Cirrhosis Before and After Liver Transplantation
Kalaitzakis, E., Josefsson, A., Castedal, M., Henfridsson, P., Bengtsson, M., Hugosson, I., Andersson, B. A., & Bjornsson, E. S. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.07.029 · Cited by 72
Prospective validation of the short form liver disease quality of life instrument
Kanwal, F., Spiegel, B. M. R., Hays, R. D., Durazo, F. A., Han, S. B., Saab, S., Bolus, R. R., Kim, S. J., & Gralnek, I. M. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03817.x · Cited by 66
Liver transplantation for primary sclerosing cholangitis
Bjøro, K., & Schrumpf, E. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.01.021 · Cited by 61
Persistent fatigue in liver transplant recipients: a two‐year follow‐up study
van Ginneken, B. T. J., van den Berg-Emons, R. J. G., van der Windt, A. E., Tilanus, H. W., Metselaar, H. J., Stam, H. J., & Geert Kazemier, M. (2009) · Clinical Transplantation · doi:10.1111/j.1399-0012.2009.01083.x · Cited by 62
Autoantigens in primary biliary cirrhosis
Jones, D. E. J. (2000) · Journal of Clinical Pathology · doi:10.1136/jcp.53.11.813 · Cited by 58
Transplantation in autoimmune liver diseases
Mottershead, M., & Neuberger, J. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.3388 · Cited by 61
“The quality of life following transplantation was significantly better than before transplantation in all aspects but at 1-year follow-up, was not predictable by the pre-transplant subjective health status or clinical factors[ 56 ].”
BackgroundEffects of liver transplantation on the nutritional status of patients with cystic fibrosis*
Colombo, C., Costantini, D., Rocchi, A., Romano, G., Rossi, G. E., Bianchi, M. L., Bertoli, S., & Battezzati, A. (2005) · Transplant International · doi:10.1111/j.1432-2277.2004.00013.x · Cited by 57
“With regard to bone mineralization, the improvement is presumably linked to a combination of factors related to transplantation, including restoration of bile flow allowing better absorption of nutrients, improvement of protein anabolism, and increase in physical activity because of better quality of life [29].”
BackgroundLiver transplantation for primary biliary cirrhosis
MacQuillan, G. C., & Neuberger, J. (2003) · Clinics in Liver Disease · doi:10.1016/s1089-3261(03)00099-0 · Cited by 60
Ruppert, K. M., Kuo, S., DiMartini, A. F., & Balan, V. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.06.043 · Cited by 56
Northup, P. G., Abecassis, M. M., Englesbe, M. J., Emond, J. C., Lee, V. D., Stukenborg, G. J., Tong, L., & Berg, C. L. (2009) · Liver Transplantation · doi:10.1002/lt.21671 · Cited by 59
Huda, A., Newcomer, R. J., Harrington, C. A., Blegen, M. G., & Keeffe, E. B. (2011) · Liver Transplantation · doi:10.1002/lt.22408 · Cited by 58
“Thus, it was not unexpected that these patients might have greater improvements in their quality of life after transplantation, as previously shown.(24) The posttransplant employment rate for patients with HCC was 14% higher than the rate for patients with alcoholic liver 98 HUDA ET AL.”
ResultReduced quality of life of patients with hepatocellular carcinoma
Bianchi, G. P., Loguercio, C., Sgarbi, D., Abbiati, R. A., Brunetti, N. D., Simone, T. D., Zoli, M., & Marchesini, G. (2003) · Digestive and Liver Disease · doi:10.1016/s1590-8658(02)00011-7 · Cited by 55
Liver transplantation for primary biliary cirrhosis: indications and risk of recurrence
Neuberger, J. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00283-6 · Cited by 55
Liver Transplantation for Cholestatic Liver Diseases in Adults
Khungar, V., & Goldberg, D. S. (2015) · Clinics in Liver Disease · doi:10.1016/j.cld.2015.08.011 · Cited by 58
Preoperative expectations and postoperative quality of life in liver transplant survivors.
Holzner, B., Kemmler, G., Kopp, M., Dachs, E., Kaserbacher, R., Spechtenhauser, B., Vogel, W., & Sperner-Unterweger, B. (2001) · Archives of Physical Medicine and Rehabilitation · doi:10.1053/apmr.2001.19013 · Cited by 61
Kim, W., Lindor, K., Malinchoc, M., Petz, J., Jorgensen, R., & Dickson, E. (2000) · Hepatology · doi:10.1053/jhep.2000.19067 · Cited by 45
Self-citationHealth-related quality of life of 256 recipients after liver transplantation
Chen, P. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i36.5114 · Cited by 47
Extrahepatic manifestations of cholestasis
Glasová, H., & Beuers, U. H. (2002) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2002.02717.x · Cited by 49
Health‐related quality of life among patients with primary sclerosing cholangitis
Haapamäki, J., Tenca, A., Sintonen, H., Barner‐Rasmussen, N., & Färkkilä, M. A. (2015) · Liver International · doi:10.1111/liv.12775 · Cited by 42
Employment and Health Insurance in Long‐Term Liver Transplant Recipients
Rongey, C. A., Bambha, K. M., Vanness, D. J., Pedersen, R. A., Malinchoc, M., Therneau, T. M., Dickson, E. R., & Kim, W. R. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2005.00961.x · Cited by 41
Self-citationLiver transplantation for primary biliary cirrhosis
Neuberger, J. (2003) · Autoimmunity Reviews · doi:10.1016/s1568-9972(02)00103-9 · Cited by 40
“Patients with end-stage cholestatic disease undergoing liver transplantation experience substantial improvement in quality of life [32].”
BackgroundAscites after liver transplantation—A mystery
Stewart, C. A., Wertheim, J. A., Olthoff, K. M., Furth, E. E., Brensinger, C. M., Markman, J. F., & Shaked, A. A. (2004) · Liver Transplantation · doi:10.1002/lt.20106 · Cited by 39
Primary sclerosing cholangitis
Mendes, F. D., & Lindor, K. D. (2004) · Clinics in Liver Disease · doi:10.1016/s1089-3261(03)00127-2 · Cited by 45
Fatigue and Sleep Quality before and after Liver Transplantation
Rodrigue, J. R., Nelson, D. R., Reed, A., Hanto, D. W., & Curry, M. P. (2010) · Progress in Transplantation · doi:10.7182/prtr.20.3.x82q1832184j4733 · Cited by 39
“Numerous studies have documented the QOL benefits associated with liver transplantation.(23-26) However, our study highlights that fatigue is a prominent symptom for many posttransplant patients and that low QOL in some areas is associated with high fatigue levels and poor sleep quality.”
BackgroundPrimary biliary cirrhosis: new perspectives in diagnosis and treatment
Prince, M. I., & Jones, D. E. J. (2000) · Postgraduate Medical Journal · doi:10.1136/pmj.76.894.199 · Cited by 37
“It is unknown whether recurrence can be prevented by differing immunosupression regimens or by deliberate HLA mismatching between donor and recipient. Quality of life is, however, markedly improved by transplantation with a high degree of patient satisfaction.”
Employment After Liver Transplantation: A Review
Huda, A., Newcomer, R., Harrington, C. A., Keeffe, E. B., & Esquivel, C. O. (2015) · Transplantation Proceedings · doi:10.1016/j.transproceed.2014.10.022 · Cited by 35
Patients' expectations and success criteria for liver transplantation
Rodrigue, J. R., Hanto, D. W., & Curry, M. P. (2011) · Liver Transplantation · doi:10.1002/lt.22355 · Cited by 37
“Gross et al.20 found that half of LT recipients reported either no improvement in pain symptoms or worse pain 1 year after LT in comparison with the period before LT, and those whose pain symptoms improved did not report complete relief.”
BackgroundInfluentialCholestatic pruritus : an update.
Vloo, C. D., & Nevens, F. (2019) · PubMed · Cited by 45
Kotarska, K., Wunsch, E., Kempińska‐Podhorodecka, A., Raszeja‐Wyszomirska, J., Bogdanos, D. P., Wójcicki, M., & Milkiewicz, P. (2014) · Journal of Immunology Research · doi:10.1155/2014/738297 · Cited by 34
“have reported similar findings and noted that limitations in several activities due to patients’ role and physical health problems virtually cease a year after LTx [27].”
Jin, X., & Khan, T. M. (2016) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2016.05.006 · Cited by 36
Assessing quality of life in primary biliary cirrhosis
Rannard, A., Buck, D., Jones, D. E. J., James, O., & Jacoby, A. (2004) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(03)00323-9 · Cited by 35
Fatigue as a Major Predictor of Quality of life in Women with Autoimmune Liver Disease
Sogolow, E. D., Lasker, J. N., & Short, L. M. (2008) · Women s Health Issues · doi:10.1016/j.whi.2007.12.005 · Cited by 34
Post-liver transplantation patient experience
Kaplan, A. J., Korenjak, M., & Brown, R. S. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.01.008 · Cited by 38
Liver transplantation in primary biliary cirrhosis.
Milkiewicz, P. (2008) · Clinical Liver Disease · doi:10.1016/j.cld.2008.02.015 · Cited by 14
“Gross and colleagues [18] applied the NIDDK LTD–QOL questionnaire for the study of various aspects of quality of life in patients who had PBC shortly before liver transplantation (mean time before grafting, 2.”
BackgroundMethodInfluentialGish, R. G., & Mason, A. L. (2001) · Clinics in Liver Disease · doi:10.1016/s1089-3261(05)70167-7 · Cited by 33
Jin, S., Yan, L.-N., Li, B., Wen, T., Zhao, J., Zeng, Y., Chen, Z., Wang, W., Xu, M., Yang, J., et al. (2010) · Transplantation Proceedings · doi:10.1016/j.transproceed.2010.04.062 · Cited by 31
PBC-transplantation and disease recurrence
Nevens, F. (2018) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2018.09.001 · Cited by 34
Fatigue in cholestatic liver disease—a perplexing symptom
Kumar, D., & Tandon, R. K. (2002) · Postgraduate Medical Journal · doi:10.1136/pmj.78.921.404 · Cited by 27
Murad, S. D., Heimbach, J. K., Gores, G. J., Rosen, C. B. B., Benson, J. T., & Kim, W. R. (2013) · Liver Transplantation · doi:10.1002/lt.23630 · Cited by 26
“The instrument version used in this study was previously validated for LT and non-LT patients.(17,18) It consists of 87 items and addresses the following domains: liver disease symptoms, Karnofsky performance status,(19) health perception, and index of well-being.”
MethodRajpurohit, S., Musunuri, B., Mohan, P. B., Bhat, G., & Shetty, S. (2023) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2023.07.417 · Cited by 30
Liver transplantation for cholestatic liver disease
Neuberger, J. (2003) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-003-0012-y · Cited by 27
“Studies have also indicated a wide range of responses, and reasons for this variation need further examination [16, 17 ].”
BackgroundIsa, F., Turner, G., Kaur, G., Kyte, D. G., Slade, A. L., Pankhurst, T., Kerecuk, L., Keeley, T., Ferguson, J., & Calvert, M. (2018) · Health and Quality of Life Outcomes · doi:10.1186/s12955-018-0951-6 · Cited by 29
“0) [32]; CLDQ [27, 29, 38, 39, 42, 43]; the NIDDK-QA [26, 28]; Rome II Modular Questionnaire; the Cleveland Global Quality of Life questionnaire (CGQOL) [34]; the Short Inflammatory Bowel Disease Questionnaire (SIBDQ) [32, 47]; Oresland scale; PSC PRO; [43] PBC-27 [35, 40, 41]; and PBC-40 [32, 35, 40, 41, 43].”
MethodInfluentialLiver Transplantation for Primary Biliary Cholangitis
Martin, E. F. (2022) · Clinics in Liver Disease · doi:10.1016/j.cld.2022.06.014 · Cited by 24
Gross, C. R., Kreitzer, M. J., Reilly-Spong, M., Winbush, N. Y., Schomaker, E. K., & Thomas, W. (2009) · Clinical Trials · doi:10.1177/1740774508100982 · Cited by 22
“Black/African American 3 (5) 0 (0) 1 (2)”
MethodInfluentialSelf-citationZhou, Y., Chen, S., Jiang, L., Guo, C., Shen, Z., Huang, P., & Wang, J. (2008) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2008.05678.x · Cited by 22
Exercise interventions for adults after liver transplantation
Pérez-Amate, È., Figuls, M. R. I., Fernández-González, M., & Giné‐Garriga, M. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013204.pub2 · Cited by 26
Extrahepatic Manifestations of Cholestatic Liver Diseases: Pathogenesis and Therapy
Pusl, T., & Beuers, U. H. (2005) · Clinical Reviews in Allergy & Immunology · doi:10.1385/criai:28:2:147 · Cited by 22
Liver transplantation for cholestatic liver diseases: Timing and disease recurrence
Cançado, G. G. L., Deeb, M., & Gulamhusein, A. F. (2025) · Hepatology · doi:10.1097/hep.0000000000001268 · Cited by 24
Lasker, J. N., Sogolow, E. D., Short, L. M., & Sass, D. A. (2010) · British Journal of Health Psychology · doi:10.1348/135910710x527964 · Cited by 26
“Gross et al. (1999) and Navasa et al. (1996) studied QOL in people with PBC PT, and Poupon, Chretien, Chazouilleres, Poupon, and Chwalow (2004) studied QOL in patients with PBC (non-transplant) compared with a control population; these studies all focused on biomedical correlates of QOL such as…”
InfluentialLiver Transplantation and Quality of Life
Rodés, J., & Navasa, M. (2000) · Canadian Journal of Gastroenterology · doi:10.1155/2000/879658 · Cited by 19
Cholestatic Liver Diseases After Liver Transplant
Polanco, N. A. P., Levy, C., & Martin, E. F. (2017) · Clinics in Liver Disease · doi:10.1016/j.cld.2016.12.011 · Cited by 21
“evidence suggests that it may not improve after LT.(61) Several mathematical models have been developed to estimate survival in patients with PBC.”
BackgroundUse of Butorphanol as Treatment for Cholestatic Itch
Golpanian, R. S., Yosipovitch, G., & Levy, C. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06392-2 · Cited by 20
Sclerosing Cholangitis and Recurrent Pyogenic Cholangitis
Ross, A. S., & Kowdley, K. V. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-6189-2.00068-8 · Cited by 17
Metadata
- Authors
- Gross, C. R., Malinchoc, M., Kim, R. W., Evans, R. W., Wiesner, R. H., Petz, J. L., Crippin, J. S., Klintmalm, G. B., Levy, M. F., Ricci, P., Therneau, T. M., & Dickson, R. E.
- Affiliations
- University of Minnesota (US)
- Mayo Clinic (US)
- Baylor University Medical Center (US)
- University of Florida (US)
- Venue
- Hepatology
- Published
- 1999-02
- Volume
- 29
- Issue
- 2
- Pages
- 356-364
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2071987840
- Semantic Scholar
- dd59f3c16f82059eeb0e53343c22f61a3b6d6815
- Cited by
- 192
- References
- 32
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 5 · 2023: 4 · 2022: 3 · 2021: 4 · 2020: 4 · 2019: 4 · 2018: 8 · 2017: 8 · 2016: 3 · 2015: 7 · 2014: 8 · 2013: 11 · 2012: 8
- FWCI
- 6.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 6056 d)
- Locations
- Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (DK 34238, R01DK034238)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Surgery › Organ Transplantation Techniques and Outcomes
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Keywords
- liver transplantation, quality of life, primary biliary cirrhosis, primary sclerosing cholangitis, cholestatic liver disease, end-stage liver disease, post-transplant outcomes, health status, clinical symptoms, physical function, social functioning, emotional functioning, health satisfaction, ascites, renal dysfunction
- MeSH terms
- Adult, Fatigue, Female, Health Status, Humans, Liver Cirrhosis, Biliary, Male, Middle Aged, Pruritus, Quality of Life, Surveys and Questionnaires, Reoperation, Sleep Wake Disorders, Cholangitis, Sclerosing, Liver Transplantation, Karnofsky Performance Status
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.